Investor & Media
AiViva is focused on developing targeted therapy for unmet needs in Ophthalmology, Dermatology, Urology, and Oncology. Our targeted approach is derived from our patented JEL™ technology, which allows treatment to be delivered directly to the source.
AiViva is dedicated to teaming with strategic partners and investors who share our vision and commitment to bring transformative therapies within our areas of focus in Ophthalmology, Dermatology, Urology, and Oncology. We also welcome the opportunity to explore novel applications of our JEL™ Technology in therapeutic areas of interest.
Please inquire by providing your contact information below: